Accurate results
for patient care
Laboratory medicine and in vitro diagnostics
JCTLM Database: higher-order reference materials, methods and services
Details : C14RM1 - human serum
| Type (acronym) | rm2 |
|---|---|
| Type | reference material |
| Unique Nomination Number | C14RM1 |
| Analyte Name | IgG PR3 ANCA |
| IUPAC IFCC Number | IgG PR3 ANCA |
| List I, II or III | List I |
| Basis for Traceability Claim | Traceable to the stated value of the mass concentration in United States National Reference Preparation (USNRP) 12-0575C (Reimer et al., Am. J. Clin. Pathol. 1982, 77, 12-19) |
| Applicable Matrices | human serum |
| Identifier Number | ERM-DA483/IFCC |
| Name | human serum |
| Certifying Organization | JRC |
| Quantity | Mass concentration |
| From (0) | 270 |
| To (0) | 270 |
| Unit (0) | mg/L |
| From (1) | 29 |
| To (1) | 29 |
| Unit (1) | mg/L |
| Level of Confidence (%) | 95 % |
| Reference to Commutability Study Publication | Please refer to certificate, and a publication on the subject of the commutability of PR3 ANCA IgG is under preparation. |
| Other Relevant Publications | Invited review article on CRMs for autoimmune diseases under preparation |
| Comments 1 | Immunoglobulin G proteinase 3 anti-neutrophil cytoplasmic autoantibodies (IgG PR3 ANCA) Each sample consists of at least 1 mL processed human serum spiked with IgG PR3 ANCA. It contains the following additives: (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), sodium azide, bezamidine chloride and aprotinin). The material is kept under argon gas in glass vials. |
| Organization Acronym | EU - JRC |
| Organization Name | European Commission - Joint Research Centre |
| Organization Website | https://crm.jrc.ec.europa.eu/ |
| Organization Country ISO Code | BE |
| Organization Country Name | Belgium |
| Analyte Category Name | Proteins |